[1] Zhao HM, Liu XF, Mao XW, et al. Intranasal delivery of nerve growth factor to protect the central nervous system against acute cerebral infarction[J]. ChinMed Sci J, 2004;19: 257-261. [2] Poduslo JF, Curran GL, Gill JS. Putrescine-modified nerve growth factor: bioactivity, plasma pharmacokinetics, bloodbrain nerve barrier permeability, and nervous system biodistribution[J]. J Neurochem, 1998;71: 1651-1660. [3] Li P, Matsunaga K, Ohizumi Y. Nerve growth factor-potentiating compounds from Picrorhizae Rhizoma[J]. Biol Pharm Bull, 2000;23: 890-892. [4] Li P, Matsunaga K, Yamakuni T, et al. PicrosidesⅠand Ⅱ, selective enhancers of the mitogen-activated protein kinase-dependent signaling pathway in the action of neuritogenic substances on PC12D cells[J]. Life Sci, 2002;71: 1821-1835. [5] Middlemiss PJ, Glasky AJ, Rathbone MP, et al. AIT-082, a unique purine derivative, enhances nerve growth factor mediated neurite outgrowth from PC12 cells[J]. Neurosc Lett, 1995;199: 131-134. [6] Pradines A, Magazin M, Schiltz P, et al. Evidence for nerve growth factor-potentiating activities of the nonpeptidic compound SR 57746A in PC12 cells[J]. J Neurochem, 1995;64: 1954-1964. [7] Angus WG, Contreras ML. Aroclor 1254 alters the binding of 125 I-labeled nerve growth factor in PC12 cells[J]. Neurosci Lett, 1995;191: 23-26. [8] Ito M, Sakai N, Ito K, et al. A novel fungal metabolite NG-061 enhances and mimics neurotrophic effect of nerve growth factor (NGF) on neurite outgrowth in PC12 cells[J]. J Antibiot, 1999;52: 224-230. [9] Li P, Matsunaga K, Yamamoto K, et al. Nardosinone, a novel enhancer of nerve growth factor in neurite outgrowth from PC12D cells[J]. Neurosci Lett, 1999;273: 53-56. [10] Li P, Matsunaga K, Yamakuni T, et al. Potentiation of nerve growth factor-action by picrosides I and Ⅱ, natural iridoids, in PC12D cells[J]. Eur J Pharmacol, 2000;406: 203-208. [11] Scandalios JG. The rise of ROS[J]. Trends Biochem Sci, 2002;27: 483-486. [12] Machlin LJ, Bendich A. Free radical tissue damage: protective role of antioxidant nutrient[J]. FASEB J, 1987;1: 441-445. [13] Huang Y, Dong Z. Oxidative stress and Alzheimer' s disease[J]. Chin J Clin Pharmacol Ther, 2005;10: 485-488. [14] Hu J, Hu G. Progress in the strudy of glutathione in Parkinson' s disease[J]. Chin J Clin Pharmacol Ther, 2003;8: 481-484. [15] Bilici M, Efe H, KorogluMA, et al. Antioxidative enzyme activities and lipid peroxidation in major depression: alteration by antidepressant treatments[J]. J Affect Disorders, 2001;64: 43-51. [16] Chandra J, Samali A, Orrenius S. Triggering and modulation of apoptosis by oxidative stress[J]. Free Radical Bio Med, 2000;29: 323-333. [17] Manton KG, Volovik S, Kulminski A. ROS effects on neurodegeneration in Alzheimer' s disease and related disorders: on environmental stresses of ionizing radiation[J]. Curr Alz Res, 2004;1: 277-293. [18] Woodruff RH, Franklin RJ. Growth factors and remyelination in the CNS[J]. Histol Histopathol, 1997;12: 459-466. [19] Patrick CWJ, Kukreti S, Mcintire LV. Quantitative effects of peripheral monocytes and nerve growth factor on CNS neural morphometric outgrowth parameters in vitro[J]. Exp Neurol, 1996;138: 277-285. [20] Johnson EM, Chang JY, Koike T, et al. Why do neurons die when deprived of tropic factors[J] ? Neurobiol Aging, 1989;10: 549-552. [21] Brinton RD, Yamazaki RS. Advances and challenges in the prevention and treatment of Alzheimer' s disease[J]. Pharm Res, 1998;15: 386-398. [22] Senthil Kumar SH, Anandan R, Devaki T, et al. Cardioprotective effects of Picrorrhiza kurroa against isoproterenol-induced myocardial stress in rats[J]. Fitoterapia, 2001;72: 402-405. [23] Singh AK, Mani H, Seth P, et al. Picroliv preconditioning protects the rat liver against ischemia-reperfusion injury[J]. Eur J Pharmacol, 2000;395: 229-239. [24] Sampath D, Jackson GR, Werrbach-perez K, et al. Effects of nerve growth factor on glutathione peroxidase and catalase in PC12 cells[J]. J Neurochem, 1994;62: 2476-2479. |